A Feasibility Study Examining the Use of Non-Invasive Focused Ultrasound (FUS) With Oral Etoposide Administration in Children With Progressive Diffuse Midline Glioma (DMG)
This study tests a new way to help medicine reach brain tumors by using special sound waves to temporarily open the brain's natural protective barrier. The goal is to see if this method safely helps a chemotherapy medicine work better for children and young adults with a difficult type of brain tumor.
This study is for children and young adults between 4 and 21 years old who have a growing brain tumor called diffuse midline glioma with a specific genetic mutation. Participants must also meet certain physical activity levels and have never taken the study chemotherapy drug before.
Participants will take a chemotherapy medicine by mouth and receive a non-invasive focused ultrasound treatment using sound waves to help the medicine reach the tumor area. Doctors will closely monitor safety, health, and how well the treatment works throughout the process.
The study is currently recruiting participants and takes place in New York, New York, in the United States.
- 1Uses non-invasive sound waves to help medicine reach brain tumors
- 2Open to patients between 4 and 21 years old with specific brain tumors
- 3Currently recruiting patients in New York, New York
No related links yet
Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.
Suggest a linkThis summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.